CD4 and neoplasm: Moreover, this mechanism of action did not require MHC-I or MHC-II expression on cancer cells, suggesting that Th1-mediated anti-tumor effect of anti-CTLA-4 Ab may not be due to direct killing by CD4+ T cells.